Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation
- PMID: 38874844
- DOI: 10.1007/s11060-024-04729-9
Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation
Abstract
Purpose: To evaluate the performance of multi-pool Chemical exchange saturation transfer (CEST) MRI in prediction of glioma grade, isocitrate dehydrogenase (IDH) mutation, alpha-thalassemia/mental retardation syndrome X-linked (ATRX) loss and Ki-67 labeling index (LI), based on the fifth edition of the World Health Organization classification of central nervous system tumors (WHO CNS5).
Methods: 95 patients with adult-type diffuse gliomas were analyzed. The amide, direct water saturation (DS), nuclear Overhauser enhancement (NOE), semi-solid magnetization transfer (MT) and amine signals were derived using Lorentzian fitting, and asymmetry-based amide proton transfer-weighted (APTwasym) signal was calculated. The mean value of tumor region was measured and intergroup differences were estimated using student-t test. The receiver operating curve (ROC) and area under the curve (AUC) analysis were used to evaluate the diagnostic performance of signals and their combinations. Spearman correlation analysis was performed to evaluate tumor proliferation.
Results: The amide and DS signals were significantly higher in high-grade gliomas compared to low-grade gliomas, as well as in IDH-wildtype gliomas compared to IDH-mutant gliomas (all p < 0.001). The DS, MT and amine signals showed significantly differences between ATRX loss and retention in grade 2/3 IDH-mutant gliomas (all p < 0.05). The combination of signals showed the highest AUC in prediction of grade (0.857), IDH mutation (0.814) and ATRX loss (0.769). Additionally, the amide and DS signals were positively correlated with Ki-67 LI (both p < 0.001).
Conclusion: Multi-pool CEST MRI demonstrated good potential to predict glioma grade, IDH mutation, ATRX loss and Ki-67 LI.
Keywords: Central nervous system; Chemical exchange saturation transfer; Genotype; Glioma; Magnetic resonance imaging.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Role of Amide Proton Transfer Weighted MRI in Predicting MGMTp Methylation Status, p53-Status, Ki-67 Index, IDH-Status, and ATRX Expression in WHO Grade 4 High Grade Glioma.Tomography. 2025 May 31;11(6):64. doi: 10.3390/tomography11060064. Tomography. 2025. PMID: 40560010 Free PMC article.
-
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.J Neurooncol. 2017 Dec;135(3):601-609. doi: 10.1007/s11060-017-2613-7. Epub 2017 Sep 4. J Neurooncol. 2017. PMID: 28871469 Free PMC article.
-
Amide Proton Transfer-weighted (APTw) Imaging and Derived Quantitative Metrics in Evaluating Gliomas: Improved Performance Compared to Magnetization Transfer Ratio Asymmetry (MTRasym).Acad Radiol. 2025 May;32(5):2919-2930. doi: 10.1016/j.acra.2024.12.054. Epub 2025 Jan 13. Acad Radiol. 2025. PMID: 39809602
-
Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System.Lab Invest. 2022 Feb;102(2):126-133. doi: 10.1038/s41374-021-00667-6. Epub 2021 Sep 9. Lab Invest. 2022. PMID: 34504304 Review.
-
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660. Neurosurg Focus. 2019. PMID: 31786548
Cited by
-
Multiparametric Chemical Exchange Saturation Transfer MRI Detects Metabolic Changes in Mild Cognitive Impairment Cases at 3.0 Tesla.Neurochem Res. 2024 Dec 9;50(1):51. doi: 10.1007/s11064-024-04307-5. Neurochem Res. 2024. PMID: 39648256
-
Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas.Front Oncol. 2024 Dec 20;14:1507335. doi: 10.3389/fonc.2024.1507335. eCollection 2024. Front Oncol. 2024. PMID: 39759149 Free PMC article.
-
Chemical exchange saturation transfer magnetic resonance imaging of the kidney: applications and challenges.Abdom Radiol (NY). 2025 May 31. doi: 10.1007/s00261-025-04980-2. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40448845 Review. No abstract available.
References
-
- Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/neuonc/noab106 - DOI - PubMed - PMC
-
- Hartmann C, Hentschel B, Wick W et al (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707–718. https://doi.org/10.1007/s00401-010-0781-z - DOI - PubMed
-
- Brendle C, Hempel JM, Schittenhelm J et al (2018) Glioma grading and determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion. Clin Neuroradiol 28:421–428. https://doi.org/10.1007/s00062-017-0590-z - DOI - PubMed
-
- Venneti S, Huse JT (2015) The evolving molecular genetics of low-grade glioma. Adv Anat Pathol 22:94–101. https://doi.org/10.1097/PAP.0000000000000049 - DOI - PubMed - PMC
-
- Ogishima T, Tamura K, Kobayashi D et al (2017) ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations. Brain Tumor Pathol 34:20–27. https://doi.org/10.1007/s10014-017-0280-1 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical